FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097565 [Registered on: 17/11/2025] Trial Registered Prospectively
Last Modified On: 14/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Dexmedetomidine for reducing succinylcholine indused myalgia in patients undergoing Electroconvulsive therapy. 
Scientific Title of Study   "To Evaluate Efficacy of Dexmedetomidine for Reducing Sucicnylcholine Induced Myalgia in Patients undergoing Electro convulsive Therapy." 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
S9966/A  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR SUCHETA SUHAS DOSHI 
Designation  JOUNIOR RESIDENT 
Affiliation  Smt Bhailal Kothari Shah Medical Institute and Research Centre Vadodara, Gujarat. 
Address  DHIRAJ HOSPITAL SUMANDEEP VIDHYPEETH WAGHODIYA VADODARA GUJRAT
Smt Bhailal Kothari Shah Medical Institute and Research Centre Vadodara, Gujarat.
Vadodara
GUJARAT
391760
India 
Phone  7083512180  
Fax    
Email  suhasdoshi2014@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr SARA MARRY THOMAS  
Designation  HOD and Profesor Department of anaesthesia  
Affiliation  Smt Bhailal Kothari Shah Medical Institute and Research Centre Vadodara, Gujarat. 
Address  DHIRAJ HOSPITAL SUMANDEEP VIDYAPEETH PIPARIYA VADODARA GUJARAT
Smt Bhailal Kothari Shah Medical Institute and Research Centre Vadodara, Gujarat. Pin code-391760
Vadodara
GUJARAT
391760
India 
Phone  9646500158  
Fax    
Email  sara.cinosh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr SARA MARRY THOMAS  
Designation  HOD and Profesor Department of anaesthesia  
Affiliation  Smt Bhailal Kothari Shah Medical Institute and Research Centre Vadodara, Gujarat. 
Address  DHIRAJ HOSPITAL SUMANDEEP VIDYAPEETH PIPARIYA VADODARA GUJARAT Pin code 391760
Smt Bhailal Kothari Shah Medical Institute and Research Centre Vadodara, Gujarat. Pin code- 391760
Vadodara
GUJARAT
391760
India 
Phone  9646500158  
Fax    
Email  sara.cinosh@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dhiraj Hospital Sumandeep vidyapeeth  
Address  SUMANDEEP VIDHYPEETH Pipariya Waghodiya, VADODARA GUJRAT Pin code-391760 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SARA MARRY THOMAS   Dhiraj Hospital   4th floor ECT room, department of Anaesthesia, SUMANDEEP VIDHYPEETH WAGHODIYA, VADODARA GUJRAT
Vadodara
GUJARAT 
96465 00158

sara.cinosh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sumandeep vidyapeeth institutional ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Group C   Comparator group will recieve 100 ml Normal Saline intravenously 10 minutes before electro convulsive therapy  
Intervention  Group D  Interventional group will recieve low dose dexmeditomidine (0.25 mcg per kg) diluted in 100 ml Normal Saline given intravenously over 10 minutes before electrocounvulsive therapy 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients willing to sign informed consent.
Patient belonging to ASA physical status 1 and 2.
Patients undergoing Electroconvulsive therapy. 
 
ExclusionCriteria 
Details  Patients unwilling to participate in study.
Patient with BMI more than 30 kg/m2.
Patient who are deaf or incapable of understanding the language.
Patient belonging to ASA physical status 3.
Patients with history of allergy to an adrenergic agonist.
Pregnancy and lactating women. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
This prospective study will help us to evaluate the efficacy of low dose intravenous Dexmedetomidine in reducing fasciculations and myalgia due to sucicnylcholine during electro convulsive therapy.  This prospective study will help us to evaluate the efficacy of low dose intravenous Dexmedetomidine in reducing fasciculations immediately after giving Sccinylcholine and myalgia due to sucicnylcholine after 60 minutes of electro convulsive therapy. 
 
Secondary Outcome  
Outcome  TimePoints 
Effect of Dexmedetomidine in attenuating blood pressure & heart rate during electro convulsive therapy.  At Base line, 5 min after drug intervention, During ECT, 3 min, 5 min, 10 min, 20 min, 30 min after ECT 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   15/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In the present study we will be comparing the efficacy of low dose of intravenous Dexmedetomidine (0.25 mcg/ kg) diluted in 100 ml Normal Saline for reducing incidence and severity of sucicnylcholine induced myalgia and fascination and optimization of hemodynamics in patients undergoing electro convulsive therapy. 
Close